Heath D F, Rose J G
Biochem J. 1985 May 1;227(3):851-65. doi: 10.1042/bj2270851.
Previous attempts to account for the labelling in vivo of liver metabolites associated with the citrate cycle and gluconeogenesis have foundered because proper allowance was not made for the heterogeneity of the liver. In the basal state (anaesthetized after 24h starvation) this heterogeneity is minimal, and we show that labelling by [14C]bicarbonate can be interpreted unambiguously. [14C]Bicarbonate was infused to an isotopic steady state, and measurements were made of specific radioactivities of blood bicarbonate, alanine, glycerol and lactate, of liver alanine and lactate, and of individual carbon atoms in blood glucose and liver aspartate, citrate and malate. (Existing methods for several of these measurements were extensively modified.) The results were combined with published rates of gluconeogenesis, uptake of gluconeogenic precursors by the liver, and citrate-cycle flux, all measured under similar conditions, and with estimates of other rates made from published data. To interpret the results, three ancillary measurements were made: the rate of CO2 exchange by phosphoenolpyruvate carboxykinase (PEPCK; EC 4.1.1.32) under conditions that simulated those in vivo; the 14C isotope effect in the pyruvate carboxylase (EC 6.4.1.1) reaction (14C/12C = 0.992 +/- 0.008; S.E.M., n = 8); the ratio of labelling by [2-14C]- to that by [1-14C]-pyruvate of liver glutamate 1.5 min after injection. This ratio, 3.38, is a measure of the disequilibrium in the mitochondria between malate and oxaloacetate. The data were analysed with due regard to experimental variance, uncertainties in values of fluxes measured in vitro, hepatic heterogeneity and renal glucose output. The following conclusions were reached. The results could not be explained if CO2 fixation was confined to pyruvate carboxylase and there was only one, well-mixed, pool of oxaloacetate in the mitochondria. Addition of the other carboxylation reactions, those of PEPCK, isocitrate dehydrogenase (EC 1.1.1.42) and malic enzyme (EC 1.1.1.40), was not enough. Incomplete mixing of mitochondrial oxaloacetate had to be assumed, i.e. that there was metabolic channelling of oxaloacetate formed from pyruvate towards gluconeogenesis. There was some evidence that malate exchange across the mitochondrial membrane might also be channelled, with incomplete mixing with that in the citrate cycle. Calculated rates of exchange of CO2 by PEPCK were in agreement with those measured in vitro, with little or no activation by Fe2+ ions.(ABSTRACT TRUNCATED AT 400 WORDS)
以往试图解释与柠檬酸循环和糖异生相关的肝脏代谢物在体内的标记情况的尝试均告失败,原因是没有充分考虑肝脏的异质性。在基础状态(饥饿24小时后麻醉)下,这种异质性最小,我们表明用[14C]碳酸氢盐进行的标记可以得到明确的解释。将[14C]碳酸氢盐输注至同位素稳态,并测量血液碳酸氢盐、丙氨酸、甘油和乳酸、肝脏丙氨酸和乳酸的比放射性,以及血糖和肝脏天冬氨酸、柠檬酸和苹果酸中各个碳原子的比放射性。(对其中几种测量的现有方法进行了广泛修改。)将这些结果与在类似条件下测量的已发表的糖异生速率、肝脏对糖异生前体的摄取以及柠檬酸循环通量相结合,并结合从已发表数据得出的其他速率估计值。为了解释这些结果,进行了三项辅助测量:在模拟体内条件下磷酸烯醇式丙酮酸羧激酶(PEPCK;EC 4.1.1.32)的CO2交换速率;丙酮酸羧化酶(EC 6.4.1.1)反应中的14C同位素效应(14C/12C = 0.992±0.008;标准误,n = 8);注射后1.5分钟肝脏谷氨酸用[2-14C] - 丙酮酸与用[1-14C] - 丙酮酸标记的比率。这个比率为3.38,是线粒体中苹果酸和草酰乙酸之间不平衡的一个指标。在充分考虑实验方差、体外测量的通量值的不确定性、肝脏异质性和肾脏葡萄糖输出的情况下对数据进行了分析。得出了以下结论。如果CO2固定仅限于丙酮酸羧化酶,并且线粒体中只有一个充分混合的草酰乙酸池,那么这些结果无法得到解释。加入其他羧化反应,即PEPCK、异柠檬酸脱氢酶(EC 1.1.1.42)和苹果酸酶(EC 1.1.1.40)的反应,也不够。必须假定线粒体草酰乙酸没有完全混合,即由丙酮酸形成的草酰乙酸存在向糖异生的代谢通道。有一些证据表明,苹果酸跨线粒体膜的交换也可能存在通道,与柠檬酸循环中的交换没有完全混合。计算得出的PEPCK的CO2交换速率与体外测量的速率一致,几乎没有或没有受到Fe2+离子的激活。(摘要截短至400字)